2026 is an execution year: lower EBITDA guidance reflects New York Medicaid pressure despite substantial facility-ramp potential [33][38].
| Quarter | Q4 FY25 |
|---|---|
| Call date | 2026-03-03 |
| Length | 63 minutes |
| EPS | $0.07 |
| EPS consensus | $0.03 |
| Revenue | $851.6M |
| Revenue consensus | $800.1M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
All ACHC earnings ยท Back to ACHC overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.